Epivax Oncology

About:

Epivax Oncology is a providence, RI and NY-based precision cancer immunotherapy company.

Website: https://www.epivaxtx.com/

Top Investors: National Institutes of Health, Morningside Venture Partners, THE CATALYTIC IMPACT FOUNDATION (CIF), Accelerate New York Seed Fund, Horatio Ventures NYC

Description:

EpiVax Oncology is a provider of a clinical research and development platform intended to offer various type of precision cancer immunotherapies. The company's platform are based on optimal neo-epitopes selected through its proprietary and validated, in-silico, predictive algorithms, enabling clients to address the unmet medical needs that are inadequately addressed by current cancer therapeutic approaches.